Statins and Non-Alcoholic Fatty Liver Disease Progression: Further Comments

被引：0

作者：

Athyros, Vasilios G. ^{[1
]}

Koumaras, Charalambos ^{[2
]}

Sfikas, George ^{[2
]}

机构：

[1] Aristotle Univ Thessaloniki, Sch Med, Hippocrat Hosp, Propedeut Dept Internal Med 2, Marmara 15, Thessaloniki 55132, Greece

[2] 424 Mil Gen Training Hosp, 1st Internal Med Clin, Thessaloniki, Greece

来源：

关键词：

CORONARY-HEART-DISEASE; STEATOHEPATITIS; ATORVASTATIN; RISK;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：673 / 674

页数：2

共 50 条

[31] Non-alcoholic fatty liver disease
Bjornsson, Einar
Angulo, Paul
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1023 - 1030
[32] Non-alcoholic fatty liver disease
Cua, IHY
George, J
HOSPITAL MEDICINE, 2005, 66 (02): : 106 - 111
[33] Non-alcoholic fatty liver disease
Tuyama, Ana C.
Chang, Charissa Y.
JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
[34] Non-alcoholic fatty Liver disease
Calderaro, Julien
Zafrani, Elie Serge
ANNALES DE PATHOLOGIE, 2010, 30 (06) : 413 - 420
[35] Non-alcoholic fatty liver disease
Farrell, Geoffrey C.
Wardell, Rebecca
Teoh, Narci
Chitturi, Shiv
INTERNAL MEDICINE JOURNAL, 2019, 49 (05) : 681 - 683
[36] Non-alcoholic fatty liver disease
Adams, LA
Angulo, P
LIVER DISEASES: ADVANCES IN TREATMENT AND PREVENTION: IN HONOUR OF HANS POPPER'S 100TH BIRTHDAY, 2004, 137 : 250 - 270
[37] Non-Alcoholic Fatty Liver Disease
Engin, Atilla
OBESITY AND LIPOTOXICITY, 2017, 960 : 443 - 467
[38] Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC Medicine, 15
[39] Non-alcoholic fatty liver disease
Alba, LM
Lindor, K
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 17 (08) : 977 - 986
[40] Non-alcoholic fatty liver disease
Sattar, Naveed
Forrest, Ewan
Preiss, David
BMJ-BRITISH MEDICAL JOURNAL, 2014, 349